Ftse Mib
34.339,32
0,55%
DAX
18.686,60
1,07%
S&P 500
5.214,08
0,51%
NASDAQ
16.346,26
0,27%
Bitcoin
62.826,33
-0,35%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Canada TSX BELLUS Health Inc (BLU) BELLUS Health Inc (BLU) Notizie

BLU

BELLUS Health (BLU)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:TSX:BLU
DataOraFonteTitoloSimboloCompagnia
28/06/202316:59PR Newswire (Canada)Annonce boursière - Réservée aux médias et aux investisseurs - GSK mène à terme l'acquisition de BELLUS SantéTSX:BLUBELLUS Health Inc
28/06/202316:57PR Newswire (Canada)Stock-exchange announcement - For media and investors only - GSK completes acquisition of BELLUS HealthTSX:BLUBELLUS Health Inc
03/09/202200:27PR Newswire (Canada)S&P Dow Jones Indices annonce des modifications à l'indice composé S&P/TSX et à l'indice S&P/TSX 60TSX:BLUBELLUS Health Inc
02/09/202223:15PR Newswire (Canada)S&P Dow Jones Indices Announces Changes to the S&P/TSX Composite Index and S&P/TSX 60 IndexTSX:BLUBELLUS Health Inc
13/12/202116:19PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - BLUTSX:BLUBELLUS Health Inc
13/12/202116:18PR Newswire (Canada)IIROC Trade Resumption - BLUTSX:BLUBELLUS Health Inc
13/12/202116:11PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - BLUTSX:BLUBELLUS Health Inc
13/12/202116:08PR Newswire (Canada)IIROC Trading Halt - BLUTSX:BLUBELLUS Health Inc
19/03/202015:28PR Newswire (Canada)IIROC Trading Halt - BLUTSX:BLUBELLUS Health Inc
04/04/201913:00PR Newswire (Canada)BELLUS Health to Present at Two Upcoming Healthcare Investor ConferencesTSX:BLUBELLUS Health Inc
04/04/201913:00PR Newswire (Canada)BELLUS Santé fera prochainement des présentations à l'occasion de conférences d'investisseurs dans le domaine des soins d...TSX:BLUBELLUS Health Inc
03/04/201913:00PR Newswire (Canada)BELLUS Santé obtient l'approbation de sa demande de drogue nouvelle de recherche aux États-Unis pour l'étude de phase 2 du...TSX:BLUBELLUS Health Inc
03/04/201913:00PR Newswire (Canada)BELLUS Health Announces Clearance of U.S. IND for BLU-5937 Phase 2 Study in Chronic Cough PatientsTSX:BLUBELLUS Health Inc
21/02/201913:00PR Newswire (Canada)BELLUS Health Presents 2018 Highlights and 2019 Corporate PlanTSX:BLUBELLUS Health Inc
21/02/201913:00PR Newswire (Canada)BELLUS Santé présente ses faits saillants de 2018 et son plan d'affaires pour 2019TSX:BLUBELLUS Health Inc
14/11/201823:00PR Newswire (Canada)BELLUS Health Updates BLU-5937 Top-Line Phase 1 Results Timeline to November 2018TSX:BLUBELLUS Health Inc
14/11/201823:00PR Newswire (Canada)BELLUS Santé fait une mise à jour du calendrier pour l'obtention des premiers résultats de la phase 1 pour le BLU-5937, at...TSX:BLUBELLUS Health Inc
31/10/201812:00PR Newswire (Canada)BELLUS Santé annonce l'émission d'un nouveau brevet américain revendiquant la sélectivité des récepteurs P2X3 comme moy...TSX:BLUBELLUS Health Inc
31/10/201812:00PR Newswire (Canada)BELLUS Health Announces Issuance of New U.S. Patent Claiming P2X3 Selectivity as a Means of Minimizing Taste Effects for its ...TSX:BLUBELLUS Health Inc
25/09/201813:00PR Newswire (Canada)BELLUS Health Announces Appointment of Clinical Advisory BoardTSX:BLUBELLUS Health Inc
25/09/201813:00PR Newswire (Canada)BELLUS Santé annonce la nomination d'un conseil consultatif cliniqueTSX:BLUBELLUS Health Inc
30/08/201813:00PR Newswire (Canada)BELLUS Health to Present at Baird 2018 Global Healthcare ConferenceTSX:BLUBELLUS Health Inc
30/08/201813:00PR Newswire (Canada)BELLUS Santé fera une présentation à la Baird Global Healthcare Conference 2018TSX:BLUBELLUS Health Inc
08/08/201813:00PR Newswire (Canada)BELLUS Health Reports Financial and Operating Results for the Second Quarter Ended June 30, 2018TSX:BLUBELLUS Health Inc
08/08/201813:00PR Newswire (Canada)BELLUS Santé annonce ses résultats financiers et opérationnels pour le deuxième trimestre terminé le 30 juin 2018TSX:BLUBELLUS Health Inc
19/07/201813:00PR Newswire (Canada)BELLUS Health Announces Patent Protection Secured in All Major Pharmaceutical Markets for Lead Drug Candidate BLU-5937TSX:BLUBELLUS Health Inc
19/07/201813:00PR Newswire (Canada)BELLUS Santé annonce que les brevets pour son médicament candidat phare le BLU-5937 ont été obtenus dans tous les princip...TSX:BLUBELLUS Health Inc
09/07/201813:30PR Newswire (Canada)BELLUS Health Initiates Phase 1 Clinical Study for its Chronic Cough Drug Candidate, BLU-5937TSX:BLUBELLUS Health Inc
09/07/201813:30PR Newswire (Canada)BELLUS Santé débute l'étude clinique de phase 1 pour son médicament candidat phare pour le traitement de la toux chroniqu...TSX:BLUBELLUS Health Inc
27/06/201817:30PR Newswire (Canada)BELLUS Santé présente les résultats précliniques du BLU-5937 et une mise à jour du calendrier pour l'étude de phase 1 a...TSX:BLUBELLUS Health Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:TSX:BLU

La tua Cronologia

BIT
BPE
Bper Banca
BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
STLAM
Stellantis NV
BIT
ENEL
Enel
BIT
NEXI
Nexi S.p.A
BIT
BAMI
Banco BPM
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
PRY
Prysmian
BIT
ENI
Eni
BIT
RACE
Ferrari NV
BIT
LDO
Leonardo
BIT
STMMI
ST Microelectronics
BIT
FBK
Finecobank
BIT
TIT
Telecom Italia
BIT
SRG
Snam
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network